Nath Bio-Genes (India) Limited

Web: nathbiogenes.com NSE: NATHBIOGEN BSE: 537291 SECTOR: Fast Moving Consumer Goods - Agricultural Food & Other Products | Add Note | View Notes

132 4(-3%)

Near 52W Low of 126

Volume

22k as on 23, Jun

Open

186

High

189

Low

182

136

VWAP

168

52 Week High

204

52 Week Low

126

Viand Research Rating

Quality Score

0/100

Growth Score

63/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

250

No. of Shares

1.9

P/E

8.15

P/B

0.56

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

6.83

ROCE

Profit Growth

Listing Date

28-Jan-14

Rank/Sector Rank

#2419/#144

Promoter Holding

45.59%

FII Holding

0.22%

DII Holding

0.01%

Price Chart

Price Performance

1 Week0%

1 Month3%

3 Months25%

6 Months12%

1 Year12%

YTD12%

Moving Average

5 Day SMA167

10 Day SMA167

20 Day SMA170

30 Day SMA168

50 Day SMA170

61 Day SMA165

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	180	171	175	183
Resistance 2	175	170	172	176
Resistance 1	172	169	170	174
Pivot Point	166	168	166	168
Support 1	163	167	163	165
Support 2	158	167	161	159
Support 3	154	166	158	157

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	HINDUNILVR	4,34,721	1850	2%	3%	11%	27%	47	46.6	0.03	15059
2	ITC	3,28,367	262	1%	0%	13%	36%	17	46.6	0.03	21018
3	NESTLEIND	2,36,006	1224	5%	9%	1%	2%	77	46.6	0.08	3545
4	VBL	1,38,141	408	2%	5%	6%	6%	55	46.6	0.13	3062
5	BRITANNIA	1,12,813	4684	1%	5%	15%	22%	56	46.6	0.29	2562
6	MARICO	1,00,850	776	0%	3%	5%	8%	0	46.6	0.13	1813
7	TATACONSUM	96,027	971	3%	2%	11%	17%	67	46.6	0.13	1547
8	UNITDSPR	94,286	1296	1%	1%	10%	1%	0	46.6	0.05	1838
9	GODREJCP	87,902	859	1%	1%	21%	25%	57	46.6	0.38	1516
10	DABUR	67,242	379	0%	1%	10%	24%	53	46.6	0.11	1869
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(0.01) 45.59%	(4.51) 45.59%	(0.01) 41.07%	(0.01) 41.05%	(0.01) 41.03%	(0.01) 41.03%
FIIs	(-0.11) 0.22%	(0.01) 0.31%	(-0.11) 0.32%	(0.21) 0.41%	(0.01) 0.21%	(0.01) 0.19%	(0.01) 0.18%	(-0.11) 0.21%	(-0.11) 0.27%	(0.11) 0.32%	(0.21) 0.22%	(-0.11) 0.07%	(0.01) 0.13%	(0.11) 0.15%	(-0.11) 0.01%	(0.01) 0.11%	(0.01) 0.07%	(0.01) 0.04%	(0.01) 0.01%
DIIs	(0.01) 0.01%	(-0.81) 0.01%	(-1.51) 0.76%	(-1.71) 2.25%	(-0.41) 3.94%	(0.01) 4.37%	(0.01) 4.37%	(0.01) 4.37%	(0.01) 4.37%	(0.01) 4.37%	(-0.31) 4.37%	(0.01) 4.62%	(0.01) 4.62%	(0.01) 4.62%	(0.01) 4.62%	(-0.21) 4.62%	(-2.31) 4.85%	(-2.21) 7.17%	(0.01) 9.38%
Public	54.17%	54.08%	53.31%	51.73%	50.24%	49.83%	49.83%	49.80%	49.76%	49.72%	49.81%	49.71%	49.65%	49.62%	49.77%	54.20%	54.02%	51.76%	49.58%
No. of Shareholders	33,031	33,550	34,122	34,207	34,911	35,056	35,423	35,834	35,132	34,263	34,365	33,502	33,960	34,749	35,470	35,484	35,610	33,926	33,272

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Sales	51.59	65.96	43.85	283.7	51.97	36.87	32.19	243.88	43.04	31.74	22.57	235.28	44.99	25.3	21.73	209	27.21
Sales Growth % (YoY)	-0.7%	78.9%	36.2%	16.3%	20.8%	16.2%	42.6%	3.7%	-4.3%	25.4%	3.9%	12.4%	65.3%	-	-	-	-
Sales Growth % (QoQ)	-21.8%	50.4%	-84.5%	445.9%	41%	14.5%	-86.8%	466.6%	35.6%	40.6%	-90.4%	423%	77.8%	16.4%	-89.6%	668.1%	-
Expenses	47.11	62.39	37.74	245.41	51.55	28.83	27.38	207.34	39.11	26.09	17.58	198.26	41.06	19.68	16.98	175	48.52
Operating Profit	4.48	3.57	6.11	38.29	0.42	8.04	4.81	36.54	3.93	5.65	4.99	37.02	3.93	5.62	4.75	34	-21.31
OPM %	8.68	5.41	13.93	13.5	0.81	21.81	14.94	14.98	9.13	17.8	22.11	15.73	8.74	22.21	21.86	16	-78.32
Other Income	3.63	4.42	4	3.83	4.4	0.48	0.08	0.13	1.36	2.54	0.06	0.12	0.26	0.06	0.2	0	-88.05
Interest	4.59	4.54	3.66	3.2	1.37	3.9	2.98	2.24	1.07	2.84	2.44	2.76	1.53	2.96	2.75	3	2.47
Depreciation	1.03	0.98	0.99	0.98	1.34	0.83	0.83	0.83	0.98	0.76	0.76	0.76	0.99	0.67	0.67	1	1.05
Profit before tax	2.49	2.47	5.46	37.94	2.11	3.79	1.08	33.6	3.24	4.59	1.85	33.62	1.67	2.05	1.53	31	-112.88
Tax %	100.4	35.22	11.72	1.74	29.86	30.08	-2.78	0.74	19.14	16.78	18.92	0.65	13.77	34.15	3.92	1	3.07
Net Profit	-0.01	1.6	4.82	37.28	1.48	2.65	1.11	33.35	2.62	3.82	1.5	33.41	1.43	1.35	1.47	31	-116.33
Net Profit Growth % (QoQ)	-100.6%	-66.8%	-87.1%	2418.9%	-44.2%	138.7%	-96.7%	1172.9%	-31.4%	154.7%	-95.5%	2236.4%	5.9%	-8.2%	-95.3%	126.6%	-
Net Profit Growth % (YoY)	-100.7%	-39.6%	334.2%	11.8%	-43.5%	-30.6%	-26%	-0.2%	83.2%	183%	2%	7.8%	101.2%	-	-	-	-
TTM Net Profit	43.69	45.18	46.23	42.52	38.59	39.73	40.9	41.29	41.35	40.16	37.69	37.66	35.25	-82.51	-83.86	-85.33	0
EPS in Rs	-0.01	0.84	2.54	19.62	0.78	1.39	0.58	17.55	1.38	2.02	0.79	17.59	0.76	0.71	0.77	16.19	-61.21

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2013	Mar 2012
Sales	445	268	248	234	230	109	97
Sales Growth %	66%	8%	6%	2%	-	12%	-
Expenses	393	217	198	185	193	89	82
Operating Profit	52	51	50	49	37	20	15
OPM %	12	19	20	21	16	18	15
Other Income	14	4	4	1	-87	1	1
Interest	16	11	9	10	11	4	2
Depreciation	4	4	3	3	3	5	5
Profit before tax	46	41	42	36	-63	12	9
Tax %	10	5	5	3	6	4	-1
Net Profit	42	39	40	35	-67	12	9
Net Profit Growth %	7.7%	-2.5%	14.3%	152.2%	-658.3%	33.3%	-
EPS in Rs	21.91	20.31	20.85	18.43	-35.46	7.34	5.75
Dividend Payout %	9	10	10	11	-6	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	-13	18	75	38	17
Cash from Investing Activity	3	-4	-27	-3	-20
Cash from Financing Activity	-4	-2	-8	-2	-22
Net Cash Flow	-13	11	39	34	-25

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2013	Mar 2012
Equity Capital	19	19	19	19	19	19	19	16	16
Reserves	661	661	625	621	591	554	523	41	30
Borrowings	138	155	123	128	110	105	93	19	11
Other Liabilities	278	180	259	61	160	114	105	82	63
Total Liabilities	1097	1014	1026	828	880	793	739	158	120
Fixed Assets	249	250	250	251	249	244	245	38	21
CWIP	0	0	0	0	0	0	0	0	0
Investments	6	6	6	6	6	5	5	0	1
Other Assets	842	759	770	571	625	543	490	121	99
Total Assets	1097	1014	1026	828	880	793	739	158	120

Delivery

Delivery Data: NATHBIOGEN

#	Date	131 22% 160	Value (Cr)	Q/T 317	Del 72	Del 1
1	21-Oct	133	0	20	67	0
2	19-Oct	136	0	44	73	0
3	16-Oct	138	0	23	45	0
4	15-Oct	138	0	21	60	0
5	14-Oct	140	0	17	59	0
6	13-Oct	136	0	28	62	0
7	12-Oct	136	0	8	62	0
8	9-Oct	138	0	18	70	0
9	8-Oct	136	0	19	71	0
10	7-Oct	137	0	21	70	0
11	6-Oct	138	0	22	68	0
12	5-Oct	134	0	21	76	0
13	1-Oct	138	0	17	59	0
14	30-Sep	143	0	15	58	0
15	29-Sep	142	0	34	69	0
16	28-Sep	144	0	37	69	0
17	25-Sep	149	0	29	55	0
18	24-Sep	150	0	23	82	0
19	23-Sep	148	1	625	97	1
20	22-Sep	148	1	235	98	1
21	21-Sep	152	2	368	96	2
22	18-Sep	147	1	390	98	1
23	17-Sep	148	0	13	79	0
24	16-Sep	146	0	29	85	0
25	15-Sep	147	0	33	90	0
26	11-Sep	148	0	44	68	0
27	10-Sep	153	0	22	83	0
28	9-Sep	152	0	61	84	0
29	8-Sep	152	0	103	93	0
30	7-Sep	153	0	26	83	0
31	4-Sep	153	0	41	78	0
32	3-Sep	153	0	40	76	0
33	2-Sep	153	0	19	76	0
34	1-Sep	152	0	38	71	0
35	31-Aug	158	0	36	68	0
36	28-Aug	157	0	48	70	0
37	27-Aug	154	0	72	91	0
38	26-Aug	153	0	40	79	0
39	25-Aug	153	0	26	71	0
40	24-Aug	155	0	20	59	0
41	21-Aug	153	0	24	60	0
42	20-Aug	154	0	59	86	0
43	19-Aug	154	0	42	64	0
44	18-Aug	155	0	55	79	0
45	17-Aug	154	0	30	75	0
46	14-Aug	155	0	44	85	0
47	13-Aug	155	0	55	87	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	250c	7c	2.53
19-Oct	257c	11c	4.24
17-Oct	268c	0	0
16-Oct	268c	8c	3.06
15-Oct	260c	4c	1.31
14-Oct	263c	6c	2.49
13-Oct	257c	49L	0.19
12-Oct	258c	4L	0.01
09-Oct	258c	53L	0.21
08-Oct	258c	13c	4.68
05-Oct	271c	30L	0.11
01-Oct	271c	3c	1.09
29-Sep	268c	6c	2.04
28-Sep	274c	17c	5.88
25-Sep	291c	8c	2.68
24-Sep	283c	51L	0.18
22-Sep	283c	5c	1.88
17-Sep	278c	12c	4.04
10-Sep	289c	19L	0.07
07-Sep	289c	0	0

Stock Checklist

Price is above from 52 week high low average: 7%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView